Cargando…

Biomarker dynamics and prognosis in breast cancer after neoadjuvant chemotherapy

Breast cancer is a biologically diverse disease with treatment modalities selected based on tumor stage and tumor biology. Distinct intrinsic subtypes and surrogate biomarker profiles play a major role for therapeutic decisions. Response rates to systemic and local treatments as well as the interact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zarotti, Cristina, Papassotiropoulos, Bärbel, Elfgen, Constanze, Dedes, Konstantin, Vorburger, Denise, Pestalozzi, Bernhard, Trojan, Andreas, Varga, Zsuzsanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741830/ https://www.ncbi.nlm.nih.gov/pubmed/34997055 http://dx.doi.org/10.1038/s41598-021-04032-x

Ejemplares similares

Discrepancies between radiological and histological findings in preoperative core needle (CNB) and vacuum-assisted (VAB) breast biopsies
por: Jörg, Inna, et al.
Publicado: (2020)

Somatic BRCA1 mutations in clinically sporadic breast cancer with medullary histological features
por: Rechsteiner, Markus, et al.
Publicado: (2018)

The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer
por: Teleki, Ivett, et al.
Publicado: (2013)

Similar lymphocytic infiltration pattern in primary breast cancer and their corresponding distant metastases
por: Sobottka, Bettina, et al.
Publicado: (2016)

A Micro CT Study in Patients with Breast Microcalcifications Using a Mathematical Algorithm to Assess 3D Structure
por: Kenkel, David, et al.
Publicado: (2017)

Stability and prognostic value of Slug, Sox9 and Sox10 expression in breast cancers treated with neoadjuvant chemotherapy
por: Riemenschnitter, Cosima, et al.
Publicado: (2013)

Ectopic axillary breast cancer in a male patient
por: Peil, Nils, et al.
Publicado: (2020)

Comparative analysis of confocal microscopy on fresh breast core needle biopsies and conventional histology
por: Elfgen, C., et al.
Publicado: (2019)

Correction to: Comparative analysis of confocal microscopy on fresh breast core needle biopsies and conventional histology
por: Elfgen, C., et al.
Publicado: (2019)

Targeted Therapy in HR+ HER2− Metastatic Breast Cancer: Current Clinical Trials and Their Implications for CDK4/6 Inhibitor Therapy and beyond Treatment Options
por: Elfgen, Constanze, et al.
Publicado: (2021)

Influence of neoadjuvant chemotherapy on prognosis of patients with synovial sarcoma
por: Wu, Yanan, et al.
Publicado: (2017)

Hemorrhage associated with hepatic artery pseudoaneurysms after regional chemotherapy with floxuridine: case report
por: Samaras, Panagiotis, et al.
Publicado: (2008)

Next Generation Sequencing of Reactive Stroma and Residual Breast Cancer Cells in Tumor Bed after Neoadjuvant Chemotherapy
por: Varga, Zsuzsanna, et al.
Publicado: (2022)

Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer
por: Alegría-Baños, Jorge A., et al.
Publicado: (2021)

Infectious Morbidity in Pediatric Patients Receiving Neoadjuvant Chemotherapy for Sarcoma
por: Willmer, Denise, et al.
Publicado: (2021)

The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery
por: Jeong, Hyehyun, et al.
Publicado: (2022)

BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
por: Tanino, Hirokazu, et al.
Publicado: (2016)

Neoadjuvant Chemotherapy Plays an Adverse Role in the Prognosis of Grade 2 Breast Cancer
por: Zhu, Xudong, et al.
Publicado: (2019)

SCD5 expression correlates with prognosis and response to neoadjuvant chemotherapy in breast cancer
por: Zhao, Weipeng, et al.
Publicado: (2021)

The Plasma Concentration of D-Dimer is Associated with Neoadjuvant-Chemotherapy Efficacy and the Prognosis in Osteosarcoma
por: Huang, Yujing, et al.
Publicado: (2021)

Tissue Biomarkers in Prognostication of Serous Ovarian Cancer following Neoadjuvant Chemotherapy
por: Khandakar, Binny, et al.
Publicado: (2014)

Postoperative Adjuvant Chemotherapy Improved the Prognosis in Locally Advanced Cervical Cancer Patients With Optimal Response to Neoadjuvant Chemotherapy
por: Feng, Xiaojie, et al.
Publicado: (2020)

A Novel Albumin-Related Nutrition Biomarker Predicts Breast Cancer Prognosis in Neoadjuvant Chemotherapy: A Two-Center Cohort Study
por: Wang, Meng-Di, et al.
Publicado: (2023)

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
por: Fasching, Peter A, et al.
Publicado: (2011)

Evaluation of the pathological response and prognosis following neoadjuvant chemotherapy in molecular subtypes of breast cancer
por: Zhao, Yue, et al.
Publicado: (2015)

Significance of intrinsic breast cancer subtypes on the long-term prognosis after neoadjuvant chemotherapy
por: Goto, Wataru, et al.
Publicado: (2018)

Extraction parameter optimized radiomics for neoadjuvant chemotherapy response prognosis in advanced nasopharyngeal carcinoma
por: Wang, Yiling, et al.
Publicado: (2021)

Internal mammary lymph nodal response to neoadjuvant chemotherapy on imaging and breast cancer prognosis
por: Adam, Richard, et al.
Publicado: (2022)

Dyslipidemia is associated with a poor prognosis of breast cancer in patients receiving neoadjuvant chemotherapy
por: Ma, Youzhao, et al.
Publicado: (2023)

Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer
por: Nolen, Brian M, et al.
Publicado: (2008)

On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer
por: Bownes, Richard J., et al.
Publicado: (2019)

FZR1 as a novel biomarker for breast cancer neoadjuvant chemotherapy prediction
por: Liu, Shuo, et al.
Publicado: (2020)

Identification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant Chemotherapy
por: Sahni, Sumit, et al.
Publicado: (2020)

Clinical effects of Apatinib combined with DOS neoadjuvant chemotherapy regimen in neoadjuvant chemotherapy for LAGC
por: Zhou, Peng-zhe, et al.
Publicado: (2021)

Network-based approach to identify biomarkers predicting response and prognosis for HER2-negative breast cancer treatment with taxane-anthracycline neoadjuvant chemotherapy
por: Jiang, Cui, et al.
Publicado: (2019)

Neoadjuvant chemoradiation versus perioperative chemotherapy followed by surgery in resectable adenocarcinomas of the esophagogastric junction: A retrospective single center analysis
por: SCHULZE, BJÖRN, et al.
Publicado: (2014)

DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis
por: Vici, Patrizia, et al.
Publicado: (2016)

Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy
por: Stoll, Gautier, et al.
Publicado: (2014)

Neoadjuvant Chemotherapy for Colon Cancer
por: Roth, Marc T., et al.
Publicado: (2020)

ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis
por: Gay‐Bellile, Mathilde, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8u83hi5p7j8qe0d01trfbstm9p